Trending...
- wine2wine Vinitaly Business Forum 2025: Equipping the wine industry with the tools to face an uncertain future - 174
- City of Chicago Announces Landmark Global Settlement To Resolve Wrongful Conviction Lawsuits Tied To Ronald Watts - 106
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
FAYETTEVILLE, Ark. & AUCKLAND, New Zealand - illiNews -- Lineus Medical is pleased to announce a new distribution agreement with Venture Medical, a 100% New Zealand–owned medical supplier based in Auckland. Venture Medical specializes in vascular access and wound care and will now add Lineus Medical's SafeBreak® Vascular, the only breakaway device for IV lines clinically proven to reduce multiple IV complications, to its portfolio. This partnership expands SafeBreak's availability to hospitals and healthcare providers throughout New Zealand.
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1. SafeBreak is cleared for all vascular lines down to two weeks of age both in the United Sates and Canada.
More on illi News
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks a significant milestone in Lineus Medical's international growth. By partnering with Venture Medical, we are expanding SafeBreak Vascular into a new market and building momentum for broader global adoption. Venture Medical's local expertise and strong customer relationships make them the right partner to drive commercial success in New Zealand."
"Signing this agreement with Venture Medical is an important step in bringing SafeBreak Vascular to in the people of New Zealand.", Vance Clement CEO of Lineus Medical stated. "Our mission is to reduce the "pains" associated with medical lines and make SafeBreak the standard of care globally."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on illi News
References
1. Data on file
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1. SafeBreak is cleared for all vascular lines down to two weeks of age both in the United Sates and Canada.
More on illi News
- Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
- Chicago: O'Hare International Airport Sets All-Time Passenger Record in July 2025
- The Hidden Triggers of Foreclosure Most Families Don't See Coming
- Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
- 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks a significant milestone in Lineus Medical's international growth. By partnering with Venture Medical, we are expanding SafeBreak Vascular into a new market and building momentum for broader global adoption. Venture Medical's local expertise and strong customer relationships make them the right partner to drive commercial success in New Zealand."
"Signing this agreement with Venture Medical is an important step in bringing SafeBreak Vascular to in the people of New Zealand.", Vance Clement CEO of Lineus Medical stated. "Our mission is to reduce the "pains" associated with medical lines and make SafeBreak the standard of care globally."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on illi News
- Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
- DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
- Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall
- Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
- IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
References
1. Data on file
Source: LineusMedical
0 Comments
Latest on illi News
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- InventHelp Inventor Develops Portable Sit-On-Scale (CLR-320)
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation
- Simpli.fi Earns Finalist Honors in the 2025 AdExchanger Awards
- Cyrus O'Leary's Introduces Cookie Dough Pybrid for Foodservice, Giving Chefs a Blank Canvas for Signature Desserts
- AHRFD Initiates Legal Proceedings Against Anwalt.de for Publishing Defamatory and False Content
- New Analysis Reveals the Complex Forces Driving the 'Great Human Reshuffle'
- Elevate Unveils GroundComm X30 at 2025 International GSE Expo in Las Vegas
- Homeless Man Charged with String of Business Burglaries in Naperville
- NEW power supply release from Kepco Dynatronix - HSP Advanced
- St. Augustine Honors Hispanic Heritage Month
- Vesica Health Receives AUA Guideline Inclusion